Skip to content

Effects of clary sage oil or linalyl acetate inhalation on patients' anxiety and stress levels before chemotherapy

Effects of 5% clary sage oil or 5% linalyl acetate inhalation on patients' anxiety and stress levels before chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0005485
Enrollment
45
Registered
2020-10-15
Start date
2016-03-21
Completion date
Unknown
Last updated
2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Inhalation of essential oil) : Participants were randomly allocated to the control group (almond oil inhalation), experimental group I (5&#37
clary sage oil inhalation), and experimental group II (5&#37
linalyl acetate inhalation). In the experimental groups, an aliquot of 1 ml of 5&#37
clary sage oil or 5&#37
linalyl acetate were dropped into a piece of gauze. The participants was allowed to inhale the oil via natural breathing. In the control group, almond oil was inhaled as the same manner. Inhalation wa

Sponsors

Korea University Anam Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects were included if they 1) did not have an abnormality in olfactory function 2) could communicate 3) did not have allergic reaction to the essential oil selected in this study 4) did not receive drug treatment or hormone therapy or essential oil therapy for a psychiatric disorder 5) were adults over 20 years old 6) were patients with stage III or higher solid cancer

Exclusion criteria

Exclusion criteria: Subjects were excluded if they 1) had an abnormality in olfactory function 2) could not communicate 3) had allergic reaction to the essential oil selected in this study 4) received drug treatment or hormone therapy or essential oil therapy for a psychiatric disorder 5) were under the age of 20 6) were not patients with stage III or higher solid cancer

Design outcomes

Primary

MeasureTime frame
Anxiety levels (visual analogue scale);Stress levels (visual analogue scale)

Secondary

MeasureTime frame
Systolic blood pressure;Diastolic blood pressure;Heart rate

Countries

Korea, Republic of

Contacts

Public ContactMoonsuk Kim

Korea University Anam Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026